H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 64 Citations 22,929 183 World Ranking 4255 National Ranking 2129

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • DNA

Her main research concerns Molecular biology, In vivo, Antibody, Antigen and Carcinoembryonic antigen. Her Molecular biology study incorporates themes from In vitro, Naked DNA, Receptor, Reporter gene and Gene. Many of her research projects under In vivo are closely connected to Linker with Linker, tying the diverse disciplines of science together.

While the research belongs to areas of Antibody, Anna M. Wu spends her time largely on the problem of Molecular imaging, intersecting her research to questions surrounding Positron emission tomography, Magnetic resonance imaging, Disease, Medical imaging and Internal medicine. Her Carcinoembryonic antigen research integrates issues from Pharmacokinetics and Transplantation. Anna M. Wu studied Quantum dot and Cellular imaging that intersect with Nanotechnology.

Her most cited work include:

  • Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics (6346 citations)
  • Arming antibodies: prospects and challenges for immunoconjugates (977 citations)
  • Expression of recombinant antibodies in mammalian cell lines. (492 citations)

What are the main themes of her work throughout her whole career to date?

Anna M. Wu focuses on Antibody, Molecular biology, In vivo, Cancer research and Biodistribution. Her studies deal with areas such as Carcinoembryonic antigen, Antigen and Pathology as well as Antibody. Her Molecular biology study which covers Gene that intersects with DNA.

Her study in the field of Molecular imaging and Preclinical imaging is also linked to topics like Linker. Her research in Cancer research focuses on subjects like Prostate cancer, which are connected to Prostate. Her work carried out in the field of Biodistribution brings together such families of science as Nuclear medicine, Ex vivo, Pharmacokinetics and Imaging agent.

She most often published in these fields:

  • Antibody (29.92%)
  • Molecular biology (26.89%)
  • In vivo (23.86%)

What were the highlights of her more recent work (between 2015-2021)?

  • Cancer research (23.48%)
  • Biodistribution (21.59%)
  • Prostate cancer (13.64%)

In recent papers she was focusing on the following fields of study:

Anna M. Wu mainly investigates Cancer research, Biodistribution, Prostate cancer, In vivo and Immunotherapy. Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Antigen, Stem cell and Antibody, Monoclonal antibody. Her Antibody study combines topics in areas such as Positron emission tomography, Internalization and Molecular biology.

Her Biodistribution research is multidisciplinary, relying on both Ex vivo, Pharmacokinetics, Radioimmunotherapy, Nuclear medicine and Molecular imaging. Her B16 melanoma study, which is part of a larger body of work in In vivo, is frequently linked to Short exposure, bridging the gap between disciplines. Her Prostate Stem Cell Antigen research incorporates elements of Preclinical imaging and Pancreatic cancer.

Between 2015 and 2021, her most popular works were:

  • An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. (168 citations)
  • Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression (145 citations)
  • First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake (60 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

Cancer research, Biodistribution, Immunotherapy, Pathology and Prostate cancer are her primary areas of study. She combines subjects such as Antigen, Molecular imaging, In vivo, Stem cell and Antibody with her study of Cancer research. While working on this project, Anna M. Wu studies both In vivo and Short exposure.

As part of one scientific family, she deals mainly with the area of Biodistribution, narrowing it down to issues related to the Pharmacokinetics, and often Lesion. Her study in Immunotherapy is interdisciplinary in nature, drawing from both Positron emission tomography, Cytotoxic T cell and CD8. As a part of the same scientific study, she usually deals with the Pathology, concentrating on Flow cytometry and frequently concerns with Immunohistochemistry, Monoclonal, Prostatectomy, Preclinical imaging and Image-guided surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics

X. Michalet;F. F. Pinaud;L. A. Bentolila;J. M. Tsay.
Science (2005)

8939 Citations

Arming antibodies: prospects and challenges for immunoconjugates

Anna M Wu;Peter D Senter.
Nature Biotechnology (2005)

1300 Citations

Expression of recombinant antibodies in mammalian cell lines.

Paul J. Yazaki;Anna M. Wu.
Methods of Molecular Biology (2004)

769 Citations

Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High-Level Targeting of Xenografts

Shi-zhen Hu;Louise Shively;Andrew Raubitschek;Mark Sherman.
Cancer Research (1996)

539 Citations

Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction.

Jonathan Ben-Ezra;David A. Johnson;John Rossi;Nathan Cook.
Journal of Histochemistry and Cytochemistry (1991)

452 Citations

Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice

Meike L. Schipper;Gopal Iyer;Ai Leen Koh;Zhen Cheng.
Small (2009)

430 Citations

Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output.

Andreas Markus Loening;Timothy David Fenn;Anna M. Wu;Sanjiv Sam Gambhir;Sanjiv Sam Gambhir.
Protein Engineering Design & Selection (2006)

425 Citations

The complete nucleotide sequence of the tryptophan operon of Escherichia coli

C. Yanofsky;T. Platt;I.P. Crawford;B.P. Nichols.
Nucleic Acids Research (1981)

390 Citations

Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies

Andrew Raubitschek;Michael C Jensen;Anna M Wu.
(1999)

332 Citations

Red-shifted Renilla reniformis luciferase variants for imaging in living subjects

Andreas Markus Loening;Anna M Wu;Sanjiv Sam Gambhir;Sanjiv Sam Gambhir.
Nature Methods (2007)

301 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Anna M. Wu

Sanjiv S. Gambhir

Sanjiv S. Gambhir

Stanford University

Publications: 131

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 62

Hedi Mattoussi

Hedi Mattoussi

Florida State University

Publications: 58

Jason S. Lewis

Jason S. Lewis

Memorial Sloan Kettering Cancer Center

Publications: 58

Dario Neri

Dario Neri

École Polytechnique Fédérale de Lausanne

Publications: 48

Igor L. Medintz

Igor L. Medintz

United States Naval Research Laboratory

Publications: 48

Shimon Weiss

Shimon Weiss

University of California, Los Angeles

Publications: 46

Anna Orlova

Anna Orlova

Uppsala University

Publications: 44

Vladimir Tolmachev

Vladimir Tolmachev

Uppsala University

Publications: 44

Christian Klein

Christian Klein

Roche (Switzerland)

Publications: 42

David M. Goldenberg

David M. Goldenberg

Pennsylvania State University

Publications: 40

Andrew M. Scott

Andrew M. Scott

La Trobe University

Publications: 38

Michael C. Jensen

Michael C. Jensen

Seattle Children's Hospital

Publications: 38

Dai-Wen Pang

Dai-Wen Pang

Nankai University

Publications: 37

Ken-Tye Yong

Ken-Tye Yong

University of Sydney

Publications: 37

Peter L. Choyke

Peter L. Choyke

National Institutes of Health

Publications: 35

Something went wrong. Please try again later.